Copeptin is now recognized as an important biomarker in the differential diagnosis of arginine vasopressin disorders, particularly in distinguishing between arginine vasopressin deficiency and resistance, as well as primary polydipsia-related polyuria-polydipsia syndromes. The gene discussed is AVP; the disease is neurohypophyseal diabetes insipidus.